Lactoferrin oral care to improve gum health during pregnancy
Official title: Effectiveness of an Oral Care Protocol Based on Lactoferrin Toothpaste and Mouthwash in Pregnant Women for the Prevention of Periodontal Disease: A Randomized Controlled Clinical Trial
Run by University of Pavia · NCT07069140 · Data updated 2026-11-12
This will test whether adding a lactoferrin mouthwash to lactoferrin toothpaste plus regular professional cleanings improves gum health in pregnant women 14–28 weeks into pregnancy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | University of Pavia Academic / other |
| Locations | 1 site (Pavia, Lombardy) |
| Status | Recruiting |
| Started | July 30, 2025 |
| Main results expected | June 1, 2026 |
| Study ends | June 10, 2026 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT07069140 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–45 who are 14–28 weeks pregnant, have periodontitis (Stages I–III, Grades A–B), at least 20 natural teeth, and can attend follow-up visits are ideal candidates.
✕Probably not a fit
People with systemic diseases affecting periodontal status, recent antibiotic or periodontal treatment, current smokers, those with high-risk pregnancies or allergies to product components, or those using conflicting medications/supplements are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, controlled trial will enroll 40 pregnant women in their second trimester and randomly assign them to two home-care regimens combined with professional dental cleanings every three months. The intervention group will use both a lactoferrin-based toothpaste and lactoferrin-based mouthwash, while the control group will use only the lactoferrin-based toothpaste. Participants will be followed for six months with periodic periodontal examinations. The primary outcome is reduction in dental plaque measured by the Plaque Index, with secondary outcomes including gingival inflammation, probing pocket depth, clinical attachment level, and other periodontal indices.
Why it matters
Potential benefit: If successful, this approach could reduce dental plaque and gum inflammation during pregnancy using accessible home oral-care products alongside routine cleanings.
How similar studies have gone: Laboratory work and small clinical studies suggest lactoferrin can reduce oral pathogens and plaque, but this specific lactoferrin mouthwash-plus-toothpaste regimen in pregnant women is relatively novel and not yet widely proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women aged between 18 and 45 years * Gestational age between 14 and 28 weeks at the time of enrollment (second trimester) * Diagnosis of periodontitis according to the 2017 World Workshop classification (Stages I-III, Grades A-B) * Presence of at least 20 natural teeth * Willingness to comply with study procedures and attend follow-up visits * Signed informed consent Exclusion Criteria: * History of systemic diseases that could affect periodontal status (e.g., diabetes mellitus, immunosuppression) * Antibiotic or anti-inflammatory therapy within 3 months prior to enrollment Current use of probiotics, antioxidant supplements, or medicated mouthwashes * Periodontal treatment within 6 months before enrollment * High-risk pregnancy or pregnancy complications (e.g., preeclampsia, gestational diabetes) * Smoking or tobacco use * Known allergy to any of the investigational product components * Participation in another clinical trial within the previous 3 months
Where it's running
-
Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
Pavia, Lombardy, Italy Recruiting
Study contacts
- Principal investigator: Andrea Scribante, Associate Professor — University of Pavia
- Study coordinator: Andrea Scribante, Associate Professor
- Email: andrea.scribante@unipv.it
- Phone: +39 0382516223
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oral Health Care During Pregnancy to Try to Improve Gum Health and Birth Outcomes
This study tests two noninvasive ways to improve dental health for pregnant people with gum disease, to see if better oral care can help pregnancy outcomes.
-
Coenzyme Q10 toothpaste with daily Limosilactobacillus reuteri probiotics to improve gum health during pregnancy
For pregnant women with gum disease, this will try whether adding a CoQ10 toothpaste and daily L. reuteri probiotic to regular cleanings reduces plaque and gum bleeding.
-
Non‑invasive tests using photos, X‑rays, questionnaires and saliva markers to detect gum disease
This project will test whether photos, dental X‑rays, questionnaires, and saliva/microbial markers can accurately detect gum disease in adults seeking dental care.
-
Improving dental care for nursing home residents to reduce infections and enhance diabetes control
This study tests if better dental care for nursing home residents can help reduce infections and improve diabetes control.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.